Johan Goossens, the non-executive director of Cryo-Save, has taken advantage of the recent slump in the stem cell storage firm's share price by increasing his stake to over 16%.
Goossens spent £116,000 to buy 800,000 shares at 14.5p each, increasing his stake to 7.5m shares, or 16.21%.
Shares in last month have fallen by over a half in the group after it scaled back expectations for the second half and beyond due to the recent economic turmoil.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It expects samples stored for the second half to be broadly in line with the 12,537 stored in the first half, while profitability the following year will be 'significantly below market expectations'.
Top Director Buys
Value: £173,124
Value: £116,000
Value: £50,250
Value: £45,000
Value: £24,000
Value: £21,600
Value: £21,600
Value: £19,900
Value: £15,000
Value: € 12,697
Top Director Sells
Value: £791,560
Value: $79,600
Value: $73,900
Value: £10,139
-
Cash in on the growth prospects of Europe's companiesOpinion Marcel Stötzel, co-portfolio manager of the Fidelity European Trust, selects three stocks
-
Is the AI boom another dotcom bubble?25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
